Skip to content

Veradermics

US · MANE #2148 by market cap Listed 2026
119.52 -4.87 -3.92%
Periodic snapshot; not a real-time feed. · 2026-11-20 20:02

About Veradermics

Veradermics, Inc. is a late clinical-stage biopharmaceutical company. It focuses on developing innovative therapeutics to address pervasive treatment challenges in highly prevalent aesthetic and dermatological conditions. The company was founded in 2019 and is headquartered in New Haven, CT.

Founded
2019
CEO
Mr. Reid Alexander Waldman, M.D.
Employees
21
Headquarters
New Haven, Connecticut, United States of America
Fiscal year end
12-31
Website
veradermics.com

Company profile

Exchange
US
Symbol
MANE
Market-cap rank
#2148
Listing date
2026-02-04
Market cap
5.04B
Float cap
3.86B
Shares out
42.20M
Float shares
32.25M

Sectors & themes

Biotechnology IPOs

Browse all sectors & themes

Quote time 2026-11-20 20:02:23 · For reference only, not investment advice and not tailored to your situation.

Veradermics discussion 0 comments

Add a comment